[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
February 6, 2019

New Cholesterol Guidelines Personalize Risk and Add Treatments

JAMA. 2019;321(8):731-732. doi:10.1001/jama.2018.21019

Last November, more than 15 000 clinicians alighted on Chicago for the American Heart Association (AHA) Scientific Sessions, the group’s annual flagship conference. The meeting featured the release of the federal government’s physical activity guidelines and results from several high-profile clinical trials, like VITAL and REDUCE-IT and DECLARE-TIMI 58. The announcements also included new cholesterol clinical practice guidelines from the AHA, the American College of Cardiology (ACC), and several other organizations, the first update since 2013.